Journal Information
Vol. 88. Issue S2.
Pages 11 (November - December 2022)
Download PDF
More article options
Vol. 88. Issue S2.
Pages 11 (November - December 2022)
Open Access
Use of corticosteroids in the treatment of periamigdalian abscesses: Is there benefit?
Maria Fernanda Chaves Danieluka,
Corresponding author

Corresponding author.
, Romualdo Suzano Louzeiro Tiagoa, Felipe Carvalho Leãob, Raphael de Santana Spirandellia, Lara Freire Bezerril Soaresa
a Departamento de Otorrinolaringologia, Instituto de Assistência Médica ao Servidor Público Estadual de São Paulo (IAMSPE), São Paulo, SP, Brazil
b Departamento de Otorrinolaringologia, Universidade de São Paulo (USP), São Paulo, SP, Brazil
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 88. Issue S2
More info
Full Text

Objective: To evaluate the benefits related to the use of corticosteroids in the adjuvant treatment of patients with periamigdalian abscess.

Material and methods: A retrospective study was conducted in a tertiary hospital of patients treated by the Otorhinolaryngology Service of the Institution, from March 2018 to February 2022. The following data were collected from the patients: gender, age, duration of disease evolution, use of medications before hospitalization, use of corticosteroids during hospitalization, antibiotic used, volume of abscess evaluated by computed tomography, drainage, drained volume, leukocyte count (leukogram) at hospital admission and after 48h, Protein C reactive (PCR) on hospital admission and after 48h, symptoms at hospital admission, clinical evolution during hospitalization and isolated microbiological agent.

Results: 90 hospitalized patients diagnosed with periamigdalian abscess were evaluated. The following parameters were not influenced on the size of the abscess: duration of disease evolution, previous use of anti-inflammatory drugs, age group, length of hospitalization (days) and leukogram at hospital admission and after 48h. In patients who used corticosteroids, no statistically significant reduction in pain was observed, in the duration of hospitalization and in the duration for acceptance of a general oral diet (p=0.490, p=0.775 and p=0.465, respectively).

Conclusion: The use of corticosteroids as adjuvant therapy in patients with periamigdalian abscess has no benefits concerning pain control, reduction in length of hospitalization or duration for acceptance of the general oral diet.

Keywords: Periamigdalian abscess; Corticosteroid; Pharyngeal infections.

Brazilian Journal of Otorhinolaryngology (English Edition)

Subscribe to our newsletter

Article options
en pt
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.